CSC-marker CD44 is known to mediate cancer cell survival, proliferation, and motility, as well as the modulation of tumor microenvironment [36,41,42], indicating CD133 and CD44 as an excellent marker set to validate a CCSC-like-phenotype. This evidence concerns the gene PROM1 and neoplasm.